Publication | Closed Access

Phase II study of thalidomide in patients with metastatic carcinoid and islet cell tumors

Endocrine OncologySurgical OncologyOncologyMedicinePathologyPhase Ii StudyIslet Cell TumorsMetastatic CarcinoidPharmacologyRadiation Oncology